Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This study is a exploratory comparison of the efficacy and safety of paricalcitol injection
with maxacalcitol injection in chronic kidney disease participants receiving hemodialysis
with secondary hyperparathyroidism.